Navigation Links
New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
Date:4/30/2013

Rochester, NY (PRWEB) April 30, 2013

Tremor, visual and auditory hallucinations, confusion and coma are neuropsychiatric side effects, and all have been associated with the use of Valacyclovir (Valtrex). (2)

“Valacyclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection.” (3) It is also the most popular drug prescribed against Genital Herpes infection due to its “ease of administration….” (1)

However, problems with brain function are just the tip of the iceberg. Drugs.com reports a laundry list of Valtrex side effects, including “Gastrointestinal side effects (that) have included nausea (up to 15% of users), abdominal pain (up to 11% of users), and vomiting (up to 6% of users). (4)

“I’ve never been able to understand why someone would take a drug to get rid of an annoying symptom, and in return get a potentially life-threatening symptom.” – Mike Davis, polyDNA

In light of the many potential side effects associated with Valtrex, polyDNA recommends Gene-Eden-VIR against the latent herpes virus. Valtrex is a chemical drug, in contrast, Gene-Eden-VIR is a natural herpes remedy that has no reported side effects.

In a post marketing clinical study, Gene-Eden-VIR was shown to be safe and highly effective against the latent herpes viruses. Over 70% of Gene-Eden-VIR users reported a reduction in herpes symptoms. (5)

Gene-Eden-VIR is highly effective against the latent herpes viruses, each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HSV. (6)

Finally, according to herpesnews.com, the cost of a month’s supply of Valtrex (90 pills), one of the most common anti-herpes medications, is $1275 for the brand name at the CVS Pharmacy. (7) The cost of the generic brand is only slightly less. In contrast, a month’s supply of Gene-Eden-VIR is $37.99. That’s over a thousand dollars less than the cost of Valtrex.

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com.

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/23528373
(2)    http://jac.oxfordjournals.org/content/57/5/945.long
(3)    http://www.drugs.com/valacyclovir.html
(4)    http://www.drugs.com/sfx/valacyclovir-side-effects.html
(5)    http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(6)    http://www.gene-eden-kill-virus.com/studies.php
(7)    http://herpesnews.com/herpes-medications/price-comparison-between-valtrex-generic-valtrex-and-acyclovir-in-united-states/

###

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10680382.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
2. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
3. Nature Materials study: Boosting heat transfer with nanoglue
4. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
5. Nature Materials study: Graphene invisible to water
6. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
7. Drink to Your (Oral) Health: Atlanta Dentist Looks at Two Recent Studies Exploring Green Tea’s Effects on Oral Health
8. Probiotic Action Explains New Research that Probiotics Help Reduce Stress Side Effects
9. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
10. ?The MedZilla.com Employment Report for January, 2013: Wrapping Up the Year in Employment Statistics: Recovery Efforts and the Coming Effects
11. University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... Aethlon Medical, Inc. (Nasdaq: AEMD ... validated the ability of the Aethlon Hemopurifier® to capture ... in immune-suppressed sepsis patients and also contribute to organ ... of the study was to validate the in ... and Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. ...
(Date:2/22/2017)... Zurich, Switzerland (PRWEB) , ... February 22, 2017 ... ... Ltd ., announced the addition of Tom Perkins as European director. Operating from ... consulting experience to Pennside. , Perkins joins Pennside after more than a ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):